12 FEB 2014 | ALTEOGEN starts collaboration in mAb biosimilar with KISSEI Pharma.
  Poster : 박종윤     Date : 15-01-25 07:51     Hit : 828    
ALTEOGEN and KISSEI Pharmaceutical Co., Ltd. (Nagano, Japan) entered into a business collaboration agreement.

Under the agreement, ALTEOGEN and KISSEI start collaboration in developing a mAb biosimilar and KISSEI underwrites the allocation of new shares to a third party from ALTEOGEN. Through this business collaboration, ALTEOGEN and KISSEI will continue to further strengthen its efforts to biopharmaceutical business.